Multiple Cardiac Sensors for the Management of Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03237858

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03237858
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, France, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03237858. Randomized; no masking; primary purpose diagnostic. Start 2017-08-30 (actual); primary completion 2020-07-21 (actual). Results posted on 2024-03-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multiple Cardiac Sensors for the Management of Heart Failure
Acronym
MANAGE-HF
Condition
Heart Failure, Congestive
Intervention (Device)
HeartLogic ON
Intervention (Device)
HeartLogic OFF
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct03237858
Content hash
586359a55f3eea4e7d3e3b885196e0cf268eebde9b481c6a565d8114f069fdb9